chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Spinal osteoarthritis, X-ray
Clinical narrative: My hips and thighs started hurting very badly like cattle prods in them like electric shock. It felt like the meat of my legs were being ripped off. I had an MRI and discovered my spine having 2 places of degeneration down to 3mm and there's a cyst inside the spine. I am close to being unable to walk. I have cortisone medication (oral) and muscle relaxers that help me limp around. The varicose vein therapy I was doing right before the shot, the locations they did treatment has turned hard and lumpy. My left arm feels like its broken, I have had that arm broken before so it feels similar. On a previous vaccine (moderna as well) I had it injected in my left arm and it felt the same way but much more extreme, like it was broken all over again.  In May of 2023 I had knee replacement. Now its swollen and dark in that same area, the joint is really stiff and painful. I saw a spinal specialist too.
Age: 50.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Abdominal pain upper, Decreased appetite, Fatigue, Injection site pain, Pyrexia
Clinical narrative: I started vomiting approximately 12 hours after vaccine. The vomiting stopped about 9 hours later. I had severe stomach pain as well. I completely lost my appetite for two days and only had water or ginger ale. The fatigue was moderate. Mild effects were shaking, fever, and pain at injection site.  I have no idea which vaccine caused the side effects.
Age: 50.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Tremor, Vomiting
Clinical narrative: I started vomiting approximately 12 hours after vaccine. The vomiting stopped about 9 hours later. I had severe stomach pain as well. I completely lost my appetite for two days and only had water or ginger ale. The fatigue was moderate. Mild effects were shaking, fever, and pain at injection site.  I have no idea which vaccine caused the side effects.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin, Blister, Rash, Rash papular, Rash pruritic
Clinical narrative: Full body rash beginning 1/9/2024. Began with blistering on hands, then extensive papular rash on rest of body excluding face and soles of feet. Also exposed to farm animals/straw/farm feed on 1/9 with potential for contact dermatitis.  I was in County when symptoms began. Flew home on 1/14. Urgent care visits 1/10 and 1/15. Began high dose steroid taper 1/10. Symptoms are slowly abating. Continue to have itchy rash on trunk to date. Followed by dermatologist. Had skin biopsies.
Age: 2.0
Sex: F
Vaccine: DTPPVHBHPB, HEPA, PNC15
Symptoms: Expired product administered
Clinical narrative: Accidently gave an expired Vaxelis vaccine to the pt.
Age: 1.08
Sex: F
Vaccine: HEPA, MMRV, VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient had no adverse effects according to the mother.
Age: 84.0
Sex: F
Vaccine: RSV
Symptoms: Cerebrovascular accident
Clinical narrative: My wife suffered a stroke several hours after receiving the vaccine.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect route of product administration
Clinical narrative: Varicella vaccine was administered Intramuscular instead of subcutaneous.
Age: 76.0
Sex: M
Vaccine: RSV
Symptoms: Death, Dyspnoea, Pneumonia, Sepsis, Tachycardia
Clinical narrative: Developed tachycardia and difficulty breathing.  Was sent to the ER 01/13/2024 and admitted to acute care for acute sepsis and pneumonia.  Died at hospital on 01/15/2024.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Contraception, Dysmenorrhoea, Fatigue, Feeling abnormal, Heavy menstrual bleeding
Clinical narrative: I suddenly got my period for the first time since probably 2020 (I take birth control to stop my periods because they are very heavy and painful, they disrupted my life and made me anemic). I was spotting on Jan 16th/beginning of Jan 17th 2024 (days after receiving the vaccine), which sometimes happens when on birth control so I brushed it off at first. On the afternoon of the 17th the "actual" period things happened (heavier bleeding, passing clots, nausea, fatigue, cramps etc). I called my college's health center in a panic due to my concerns, and was told that its likely it was caused by the vaccine, but that there was no immediate cause for concern unless more severe bleeding/other symptoms happened. I was unable to go to my classes on the 18th and 19th due to my period because I was in pain and miserable feeling. Today (jan 24th) would now be considered the 9th day of my period, and I am still bleeding. It is pretty light though. (My periods used to be 8 days before taking birth control so not hugely concerning yet). I had an appointment with the health center yesterday and was told that it's possible I may even continue bleeding/spotting into next week, but it should continue to lessen and will hopefully go back to my more recent "normal" experience of not having my period again on this birth control.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Muscle spasms, Nausea
Clinical narrative: I suddenly got my period for the first time since probably 2020 (I take birth control to stop my periods because they are very heavy and painful, they disrupted my life and made me anemic). I was spotting on Jan 16th/beginning of Jan 17th 2024 (days after receiving the vaccine), which sometimes happens when on birth control so I brushed it off at first. On the afternoon of the 17th the "actual" period things happened (heavier bleeding, passing clots, nausea, fatigue, cramps etc). I called my college's health center in a panic due to my concerns, and was told that its likely it was caused by the vaccine, but that there was no immediate cause for concern unless more severe bleeding/other symptoms happened. I was unable to go to my classes on the 18th and 19th due to my period because I was in pain and miserable feeling. Today (jan 24th) would now be considered the 9th day of my period, and I am still bleeding. It is pretty light though. (My periods used to be 8 days before taking birth control so not hugely concerning yet). I had an appointment with the health center yesterday and was told that it's possible I may even continue bleeding/spotting into next week, but it should continue to lessen and will hopefully go back to my more recent "normal" experience of not having my period again on this birth control.
Age: 0.5
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Used expired diluent to mix vaccine.  Normal saline expired on 11/01/23.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Severe Hives
Age: 41.0
Sex: M
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse affects.  Vaccine dose noted to be expired after administration. Will repeat dose at next visit as patient left clinic before discovery.
Age: 16.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse reaction noted, what happened was that the wrong age group vaccine was administered to client. She was suppose to be given 12+ yrs old group vaccine but was given 5-11 yrs vaccine and did not get the correct dosage.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Vaccine Administration Error: 1/10/24    This MA drew up 0.1 ml of diluent for the pfizer covid vaccine 6m - 4 years instead of 1.1 of diluent. This MA confirmed with trainer onsite and trainer agreed that the vaccine consistency looked right. Vaccine was given to child. Afterwards, this MA checked in with multiple staff and confirmed that the wrong amount of diluent was put on vial. This MA let provider know. Provider will call patient's guardian to explain error. Provider confirmed that no adverse event occurred.
Age: 0.17
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Expired product administered
Clinical narrative: Inadvertently gave expired Vaxelis to child. Upon pulling vial out of the refrigerator, I checked the expiration date. However, I read June instead of Jan and proceeded to administer the vaccine to the child. Will call the parents of the child to readminister as needed.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain, Paraesthesia, Product administered at inappropriate site
Clinical narrative: Vaccine site was given about 3 fingers too high into the shoulder.  Having pain lifting arm and weakness at this time. Pain radiating into neck and some tingling in left hand. Had not experienced this with past vaccines. Ibuprofen is not helping with the pain/inflammation.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 1.17
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: generalized rash
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Needle issue
Clinical narrative: When i pulled off the cap for the needle, the entire top part of the vaccine came with it.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac, Myocardial bridging, Myocardial infarction, Troponin
Clinical narrative: I had a minor heart attack. Different than previous coronary events - unrelated. Previous events were dissections, this was not. When catheter was inside my heart, no blockages were found. No dissections. They discovered I have a myocardial bridge, and they assume this caused the heart attack, but we don't really know for sure. I went for a run that morning, and after cooling down is when the heart attack occurred.
Age: 17.0
Sex: M
Vaccine: TYP
Symptoms: Oropharyngeal pain
Clinical narrative: Pt states he was having throat pain about 5 minutes after receiving immunization. Pt is doing better and was looked at by Medical professional and given Benadryl
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: Cold symptoms that started a few weeks ago and are worsening.
Age: 11.0
Sex: F
Vaccine: FLU4, HEP, HPV9, IPV, MMRV, MNQ, TDAP
Symptoms: Malaise, Vomiting
Clinical narrative: Patient was cooperative with vaccination and appeared to be fine.  She waited with her mother and sister for about ten minutes after vaccination, and then became ill with profuse vomiting.  She was not pale or sweaty and was alert and oriented.  She waited for about ten more minutes after the emesis and appeared to be fine before leaving the clinic.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotonia, Thrombosis
Clinical narrative: Patient reported her left arm went limp. She called an ambulance that took her to the hospital. She remained there and was diagnosed with a blood clot in her right arm.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Dysphagia, Erythema, Lymphadenopathy, Pharyngeal erythema, Rash macular
Clinical narrative: Strange sensation - felt like he was unable to swallow. Benadryl given as advised by on-call triage. In office exam, no SOB, no stridor, throat is red, adenopathy, facial redness, facial swelling, red macular rash. Today throat felt tight.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Streptococcus test, Swelling face, Throat tightness
Clinical narrative: Strange sensation - felt like he was unable to swallow. Benadryl given as advised by on-call triage. In office exam, no SOB, no stridor, throat is red, adenopathy, facial redness, facial swelling, red macular rash. Today throat felt tight.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Nasopharyngitis, Pain in extremity, Pruritus, Skin warm
Clinical narrative: 6x6 inch red  enlarge area , itching  hot large , cold like symptoms, sore arm.  patient took tylenol still having symptoms if worsen seek medical attention
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Nasal congestion, Pyrexia
Clinical narrative: Headache, stuffy nose, fever, cough.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Headache, stuffy nose, fever, cough.
Age: 60.0
Sex: M
Vaccine: COVID19-2, RSV
Symptoms: Thrombophlebitis, Ultrasound scan
Clinical narrative: Developed right-side peripheral vein thrombophlebitis,  in right side of  neck. No previous history of thrombosis /thrombophlebitis
Age: 2.17
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash papular, Rash pruritic
Clinical narrative: Mother of client reports "rash" on bilateral knees that she describes as "patchy", "red" and slightly raised. Client's mother is unsure when the rash began, but states she noticed it at approximately 1100 on 01/23/2024 when changing the client's diaper. Client's mother states that area does not appear to itch or cause the client pain. Client's mother denies any other symptoms observed in client including fever. Client's mother denies external use of any new soaps, lotions, or detergents. Client's mother advised to monitor area, and see a medical professional if the area does not improve or worsens.
Age: 16.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: provider asked to administer flu shot, flu shot administered, went to document and flu shot had already been documented that it was given on 10/19/2023
Age: 0.83
Sex: M
Vaccine: DTAPIPV, PNC15
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Kinrix was given instant of Infarix and IPOL, no treatment needed. No adverse reactions per parent report.
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site rash, Rash, Rash pruritic
Clinical narrative: Rash developed on upper arm near injection site.  Was very itchy.  Spread across chest, neck and eye lids after a few days.  After a week, it had spread to torso and then legs.
Sex: M
Vaccine: PNC, PPV
Symptoms: Empyema, Pneumonia pneumococcal, Streptococcus test
Clinical narrative: pneumonia; empyema; This spontaneous report has been downloaded from a regulatory agency, referring to a male patient of an unspecified age (age group reported as 10-14). No information regarding the patient's medical history, concurrent conditions, and concomitant medications was provided.  On an unknown date, the patient was vaccinated with pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection (dose, route of administration, anatomical location, lot number and expiration date were not reported). On unknown dates, the patient was vaccinated with three doses of pneumococcal vaccine conj 7v (crm197) (PREVENAR) (dose, route of administration, anatomical location, lot number and expiration date were not reported). All the vaccines were administered for prophylaxis.  On unknown dates in 2019, the patient experienced Streptococcus pneumoniae pneumonia and pleural empyema. On an unknown date in 2019, Streptococcus pneumoniae serotyping was performed (results not available). The outcome of the events was not reported.  The causal relationship between the events and suspected vaccines was not reported.  Upon internal review, the events of Streptococcus pneumoniae pneumonia and empyema were determined to be medically significant.
Age: 33.0
Sex: F
Vaccine: COVID19-2, FLUR4
Symptoms: Brain fog, Dizziness, Fatigue, Headache, Tachycardia
Clinical narrative: Symptoms of ME/CFS and/or POTS - dizziness, fatigue, headaches, brain fog, postural tachycardia - all in varying intensities and duration each day.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive
Age: 63.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Injection site irritation
Clinical narrative: Injection site irritation.
Age: 91.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Injection site irritation
Clinical narrative: Injection site irritation
Age: 0.25
Sex: M
Vaccine: RSV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given wrong vaccine.  No adverse reactions noted.  More education provided to staff regarding the two RSV vaccines clinic has.
Age: 64.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Injection site irritation
Clinical narrative: Injection site irritation.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Computerised tomogram normal, Dizziness, Electrocardiogram normal
Clinical narrative: Within 12 hours of receiving  the vaccine, I began to have fever & chills with terrible muscle tension &,headache.  The symptoms subsided over 24 hour time frame. On 12/24/23 I woke up with dizziness ,that eventually subsided that morning, but balance was not normal.  On the morning of 12/25/23 I woke up with extreme dizziness.  The room & pictures on the wall were moving & I wasn't .  My balance was terrible so I was taken to the Hospital by car.  There I was evaluated for issues with my heart, blood pressure & balance.  It was determined that I did not have a heart attack or stroke & a CT scan confirmed there was not a brain tumor.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle tightness, Pyrexia
Clinical narrative: Within 12 hours of receiving  the vaccine, I began to have fever & chills with terrible muscle tension &,headache.  The symptoms subsided over 24 hour time frame. On 12/24/23 I woke up with dizziness ,that eventually subsided that morning, but balance was not normal.  On the morning of 12/25/23 I woke up with extreme dizziness.  The room & pictures on the wall were moving & I wasn't .  My balance was terrible so I was taken to the Hospital by car.  There I was evaluated for issues with my heart, blood pressure & balance.  It was determined that I did not have a heart attack or stroke & a CT scan confirmed there was not a brain tumor.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Balance test, Blood test, Depression, Electronystagmogram, Keratoneuralgia
Clinical narrative: Corneal neuropathy centralized, PPPD, severe tinnitus both ears, blurry vision, depression
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Magnetic resonance imaging, Persistent postural-perceptual dizziness, Tinnitus, Vision blurred
Clinical narrative: Corneal neuropathy centralized, PPPD, severe tinnitus both ears, blurry vision, depression
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Dyspnoea, Sleep disorder
Clinical narrative: Extremely sharp stabbing pains in abdomen that were very intense, kept waking me up, would last for maybe a minute at a time but when they hit, they would take my breath away because of the intensity.  Attacks kept occurring for about 24 hours.
Age: 51.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Injection site nodule
Clinical narrative: Patient had two vaccines administered 12/15/23 (Adacel in right arm, Fluzone Quad in left arm). She came in last night 1/23/24 stating that she has a nodule in her right arm where the adacel was administered. She stated it does not hurt but wanted to make sure it was okay. I told her that nodules can happen and can take a few weeks to go away. I told her to reach out to doctor if it becomes painful or larger. She was okay with this response
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Loss of consciousness, Vomiting
Clinical narrative: Patient passed out and vomited, 10 minutes after receiving vaccine.
Age: 0.25
Sex: M
Vaccine: HEP
Symptoms: Infant irritability, Injection site erythema
Clinical narrative: Normal after vaccine symptoms such as fussiness, redness at injection site.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755652
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    ID MOD-2024-755863
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755864
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755865
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755867
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    ID MOD-2024-755868
Age: 29.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema, Injection site pain, Mobility decreased, Muscular weakness, Pruritus
Clinical narrative: Pain noted to the injection site, difficulty in raising the arm, fingers on the left hand feel weak, constant dull/ache that gets painful when pressed on, itching (resolved at time of report), redness at injection site. Will be sent to Urgent Care for medical evaluation.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena Argus ID MOD-2024-755869
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755870
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755871
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755872
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755873
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755874
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755876
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755877
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena Argus ID MOD-2024-755878
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755879
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755880
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755881
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755882
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755883
Age: 1.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered, Underdose
Clinical narrative: Vaccine solution accidentally partially ejected from syringe prior to injection.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena Argus ID MOD-2024-755884
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755885
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755886
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderena ID MOD-2024-755887
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna  ID MOD-2024-755888
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755889
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755891
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna Argus ID MOD-2024-755892
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755893
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755895
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Spikevax was given after the 30 day thaw. Moderna preformed a lot assessment and determined ther vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.    Moderna ID MOD-2024-755896
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC20, RSV, RV5
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Nursing administered the RSV Abrysvo vaccine to a 2-month-old infant instead of Nirvisimab.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Chills, Depression, Myalgia, Suicidal ideation
Clinical narrative: Patient has never  had any history of depression , adverse mood behavior ,  or suicidal thoughts. The next day she experienced a depression episode so badly that lasted the whole day and thoughts of suicide. She said if there was a gun in the house she would have shot herself. The next day the depression episode was gone and she experienced severe muscle aches, pains and chills along with joint pain. This lasted two days to Monday.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC20, RSV, RV5
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Nursing administered the RSV Abrysvo vaccine to a 4-month-old infant instead of the Nirsivemab.
Age: 59.0
Sex: F
Vaccine: COVID19, FLU4, RSV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event occurred.  Client was 59 years old at time of RSV Vaccination
Age: 11.0
Sex: M
Vaccine: COVID19, FLU4, MNQ, TDAP
Symptoms: Product administration error
Clinical narrative: COVID vaccine administered in error
Age: 0.17
Sex: F
Vaccine: DTPPVHBHPB, RV5
Symptoms: Infant irritability, Injection site swelling
Clinical narrative: Mom called office stating pt was experiencing golf ball size swelling in left leg at injection site within a few hours of immunization administration. Patient was more irritable/fussy. Was seen in office later that afternoon for recheck by primary care provider. no medications given. advised on conservative management and signs to watch for/when to call back
Age: 0.17
Sex: M
Vaccine: DTPPVHBHPB, PNC20, RV5
Symptoms: Crying, Peripheral swelling, Screaming, Swelling
Clinical narrative: Mom called reporting pt had golf ball size swelling shortly after receving vaccines at 2 month visit that progressed into swelling below pt knee. Pt screaming and inconsolable for over an hour. advised mom to take patient to ED. was taken to ED and given tylenol. Pt sent home on observation. mom to try cold compress as needed as well for swelling.
Age: 67.0
Sex: F
Vaccine: FLU4, PNC20
Symptoms: Wrong product administered
Clinical narrative: Administered regular flu vaccine instead of high-dose flu vaccine
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Upon reconciling during precharting patient's immunizations, the flu vaccine she had gotten at facility was not viewable in patient's chart.  Patient had told us she would like one and since a query was selected prior to visit, I assumed she had not gotten one.  After giving the patient her flu vaccine, I went to enter the vaccine information in patient's chart, only to discover "Go Reconcile" popped up. It had not popped up any other time during precharting. I clicked on it which is where I discovered she had received the flu vaccine in September 2023.
Age: 1.0
Sex: M
Vaccine: HIBV
Symptoms: Chills, Peripheral coldness, Pyrexia, Screaming
Clinical narrative: Mom called into the office after hours and spoke with a nurse. Mom stated patient's fever spiked to 102. Per mom, he was screaming, shivering, and his extremities were cold to the touch.
Age: 76.0
Sex: M
Vaccine: RSV
Symptoms: No adverse event, Product preparation issue
Clinical narrative: I ACCIDENTLY FORGOT TO MIX THE LIQUID ADJUVANT TO THE ANTIGEN POWDER COMPONENT, THUS I JUST GAVE THE LIQUID ADJUVANT ONLY.  IT DIDN'T SEEM TO HURT THE PATIENT. HE SAID HE WOULD COME IN AND RECEIVE THE AREXVY SHOT AT HIS NEAREST CONVENIENCE. THERE DIDN'T SEEM TO BE ANY EVENT OR OUTCOME FROM THE MISTAKE, EXCEPT THAT HE IS GOING TO HAVE TO COME BACK AND GET THE AREXVY SHOT SHOT AGAIN.
Age: 75.0
Sex: M
Vaccine: FLU4, RSV
Symptoms: Joint swelling
Clinical narrative: Patient states after he received both vaccines, he had significant swelling in his knees. It is getting better with time. Also stated he was previously in hospital within the month before for an angioplasty (stent). Advised patient to go to the MD to get seen if it persisted.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac stress test, Electrocardiogram, Extra dose administered, Supraventricular tachycardia
Clinical narrative: Pt received 2nd pfizer vaccine on 4-13-21 and on 4-18-21 he presented to the ER with Supraventricular tachycardia.
Age: 82.0
Sex: M
Vaccine: TD
Symptoms: Blood glucose decreased, Head injury, Seizure
Clinical narrative: Patient was an 82 year old male with alzheimer's.  He came to the pharmacy with his wife.  She stated he was nervous to have the shot.  He did not really speak.  Approximately 45 minutes after the vaccine he had a seizure at the checkout and hit his head.  9-1-1 was contacted and an ambulance took him to hospital.  The wife stated that she had given him glucose just prior because she thought his blood sugar had dropped.  The EMT felt that the issue was related to the low blood sugar because he was diaphoretic
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site swelling, Injection site vesicles
Clinical narrative: pt had a blistery red raised rash at injection site
Age: 42.0
Sex: F
Vaccine: UNK
Symptoms: Gait disturbance, Mobility decreased
Clinical narrative: Other abnormalities of gait and mobility on 2023-11-06.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Streptococcus pneumoniae pneumonia; This spontaneous report as received from a Surveillance System refers to an adult female patient of unknown age (age group reported as 45 and 49). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On an unknown date, the patient was vaccinated with 2 doses of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection (dose, route of administration, anatomical location, lot number and expiration date were not reported).   On an unknown date in 2014, the patient experienced Pneumonia (Streptococcus pneumoniae pneumonia). At the time of the report, Streptococcus pneumoniae serotyping was not available. The outcome of the event was not reported.  The causal relationship between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not reported.  Upon internal review, the event was determined to be medically significant event.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Pneumonia; This spontaneous report has been downloaded from Regulatory Autohrity on 12-JAN-2024.   This spontaneous report has been received from Regulatory Authority, regarding a female patient between 10-14 years-old.  The patient's pertinent concurrent conditions, medical history, past drug reactions or allergies, and concomitant therapies were not provided.   On an unknown date, the patient was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23), injection (strength, exact dose, route and site of administration, lot number, and expiration date were not provided), for prophylaxis.   On an unknown date in 2017, streptococcus pneumoniae serotyping was not available. In this same date, Streptococcus pneumoniae pneumonia (Pneumonia pneumococcal) developed.   At the time of reporting, the outcome of the event and the causality assessment between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) were not reported.    Upon internal review, the event Streptococcus pneumoniae pneumonia (Pneumonia pneumococcal) was considered as medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumococcal infection, Pneumonia pneumococcal
Clinical narrative: Other|Pneumonia; Other|Pneumonia; This spontaneous report has been downloaded from Regulatory Authority referring to a 55-59 year old (age group: adult) male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). Total 1 dose was given.  On an unknown date in 2015, the patient experienced Pneumococcal infection and Streptococcus pneumoniae pneumonia. On an unknown date in 2015, streptococcus pneumoniae serotyping was Not Available. At the time of reporting, the outcome of the events was not known.    The causal relationship between Pneumococcal infection and Streptococcus pneumoniae pneumonia and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was unknown.  Upon internal review, the events of Pneumococcal infection and Streptococcus pneumoniae pneumonia was determined to be medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumococcal infection, Pneumonia pneumococcal
Clinical narrative: Pneumonia; This spontaneous report has been downloaded from the Surveillance System concerning to an elderly (age: 65-69 years old) male patient. The patient's medical history included vaccines given (unspecified). The patient's concurrent conditions and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered for prophylaxis (strength, volume of injection, lot #, expiry date, anatomical location and route of administration was not provided).   On an unknown date in 2020, the patient experienced pneumonia (Pneumonia pneumococcal) (also reported as other clinical category and other sterile site). The streptococcus pneumoniae serotyping was not available. At the time of reporting, the outcome of the event was unknown.  The causal relationship between pneumonia pneumococcal and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not provided.   Upon internal review, Pneumococcal infection and Pneumonia pneumococcal  were determined to be medically significant.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Pneumonia; This spontaneous report has been downloaded from the database concerning to an elderly (age: 80-84 years old) female patient. The patient's medical history included vaccines given (unspecified). The patient's concurrent conditions and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered for prophylaxis (strength, volume of injection, lot #, expiry date, anatomical location and route of administration was not provided).   On an unknown date in 2020, the patient experienced pneumonia (Pneumonia pneumococcal). The streptococcus pneumoniae serotyping was not available. At the time of reporting, the outcome of the event was unknown.  The causal relationship between pneumonia pneumococcal and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not provided.   Upon internal review pneumonia pneumococcal  was determined to be medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumococcal infection
Clinical narrative: Pneumococcal infection; This spontaneous report as received from a Surveillance System refers to an adult male patient of unknown age (age group reported as 45 and 49). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On an unknown date, the patient was vaccinated with 2 dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis.    On an unknown date in 2014, the patient experienced Pneumococcal infection. At the time of the report, Streptococcus pneumoniae serotyping was not available.. The outcome of the event was not reported.  The causal relationship between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not reported.  Upon internal review, the event was determined to be medically significant event.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Streptococcus pneumoniae pneumonia; This spontaneous report as received from a Regulatory Authority refers to an adult female patient of unknown age (age group reported as 40 and 44). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On an unknown date, the patient was vaccinated with 1 dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis.    On an unknown date in 2014, the patient experienced Pneumonia (Streptococcus pneumoniae pneumonia). At the time of the report, Streptococcus pneumoniae serotyping was not available. The outcome of the event was not reported.  The causal relationship between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not reported.  Upon internal review, the event was determined to be medically significant event.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia, Streptococcus test positive
Clinical narrative: Pnemonia; This spontaneous report has been downloaded from database.  This spontaneous report refers to an adult (also reported as 40-44 years-old) female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered as prophylaxis (strength, exact dose, route of administration, anatomical location, lot #, and expiration date were not provided).  On an unknown date in 2020, the patient experienced pneumonia (pneumonia pneumococcal). On the same date, streptococcus pneumoniae serotyping was not available.    At the time of this report, the outcome of the event and the causality assessment between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) were not reported.   Upon internal review, pneumonia pneumococcal was determined to be a  medically significant event.
Sex: M
Vaccine: PPV
Symptoms: Pneumonia pneumococcal, Streptococcus test positive
Clinical narrative: Pneumonia; This spontaneous report has been downloaded from Regulatory Authority.   This spontaneous report refers to an adult (also reported as 30-34 years-old) male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered as prophylaxis (strength, exact dose, route of administration, anatomical location, lot #, and expiration date were not provided).  On an unknown date in 2020, the patient experienced pneumonia (pneumonia pneumococcal). On the same date, streptococcus pneumoniae serotyping was not available.   At the time of this report, the outcome of the event and the causality assessment between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) were not reported.   Upon internal review, pneumonia pneumococcal was determined to be a  medically significant event.
Sex: F
Vaccine: PPV
Symptoms: Pleural effusion, Pneumococcal infection
Clinical narrative: Other; Pleural effusion; This spontaneous report has been downloaded from Regulatory Authority.  This spontaneous report refers to an elderly (also reported as 65-69 years-old) female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered as prophylaxis (strength, exact dose, route of administration, anatomical location, lot #, and expiration date were not provided).  On an unknown date in 2020, the patient experienced pneumococcal infection, and pleural effusion (infectious pleural effusion). On the same date, streptococcus pneumoniae serotyping was not available.    At the time of this report, the outcome of the events and the causality assessment between the events and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) were not reported.   Upon internal review, pneumococcal infection and infectious pleural effusion were determined to be a  medically significant events.